The FDA is planning to only ask for one pivotal clinical trial instead of the long standard of two trials for drug approval. The present FDA commissioner believes it carries the same statistical power ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Takeshi Ebisawa, sentenced to 20 years in prison last week, believed he was selling weapons-grade plutonium to Iran ...

Pharmacogenomics is central to the advancement of personalized medicine, promising improved treatment efficacy and reduced adverse effects through the integration of genetic insights into clinical ...

Human metapneumovirus (HMPV), a respiratory virus with no vaccine and no targeted antiviral treatment, is among the ...

In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

A team of UC Santa Barbara engineering and molecular biology graduate students has developed software to accelerate the discovery process for therapies aimed at treating Alzheimer’s and other diseases ...

A newly identified protein essential to the survival of trypanosome parasites could offer a highly targeted route for future ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...